0001104659-13-018480.txt : 20130307 0001104659-13-018480.hdr.sgml : 20130307 20130307183057 ACCESSION NUMBER: 0001104659-13-018480 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130225 FILED AS OF DATE: 20130307 DATE AS OF CHANGE: 20130307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Westphal Christoph H CENTRAL INDEX KEY: 0001291961 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35403 FILM NUMBER: 13674801 MAIL ADDRESS: STREET 1: C/O ALNYLAM PHARMACEUTICALS, INC STREET 2: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verastem, Inc. CENTRAL INDEX KEY: 0001526119 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273269467 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 440 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-252-9300 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 440 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 a4.xml 4 X0306 4 2013-02-25 0 0001526119 Verastem, Inc. VSTM 0001291961 Westphal Christoph H C/O VERASTEM, INC. 215 FIRST STREET, SUITE 440 CAMBRIDGE MA 02142 1 1 1 0 Chief Executive Officer Common Stock 2013-02-25 4 L 0 100 9.93 A 739095 D Common Stock 2013-02-25 4 L 0 259 9.95 A 739354 D Common Stock 2013-02-25 4 L 0 41 9.96 A 739395 D Common Stock 2013-02-25 4 L 0 200 9.98 A 739595 D Common Stock 2013-02-25 4 L 0 200 9.99 A 739795 D Common Stock 2013-03-05 4 P 0 800 9.47 A 740595 D Common Stock 2869841 I By Longwood Fund, L.P. Common Stock 125714 I By the Fountain Irrevocable Trust of 2010 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 20, 2012. Represents a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $9.39 to $9.50, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 2 to this Form 4. Longwood Fund GP, LLC is the sole General Partner of Longwood Fund, L.P. Christoph Westphal, M.D., Ph.D., Richard Aldrich and Michelle Dipp, M.D., Ph.D. (collectively, the "Managers") are managers of Longwood Fund GP, LLC, and, as such, may be deemed to have shared voting and dispositive power with respect to the issuer's securities held by Longwood Fund L.P. (the "Longwood Shares"). Each of the Managers disclaims beneficial ownership of the Longwood Shares, except to the extent of their respective pecuniary interest therein, and the inclusion of the Longwood Shares in this report shall not be deemed an admission of beneficial ownership of the Longwood Shares for purposes of Section 16 or for any other purpose. /s/ Paul Brannelly, attorney-in-fact 2013-03-07